300 related articles for article (PubMed ID: 17156345)
1. Combined mediator blockade or topical steroid for treating the unified allergic airway.
Barnes ML; Menzies D; Fardon TC; Burns P; Wilson AM; Lipworth BJ
Allergy; 2007 Jan; 62(1):73-80. PubMed ID: 17156345
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
[TBL] [Abstract][Full Text] [Related]
3. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma.
Pedroletti C; Lundahl J; Alving K; Hedlin G
Pediatr Allergy Immunol; 2008 May; 19(3):219-26. PubMed ID: 18399898
[TBL] [Abstract][Full Text] [Related]
4. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
[TBL] [Abstract][Full Text] [Related]
6. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma.
Wilson AM; Orr LC; Sims EJ; Dempsey OJ; Lipworth BJ
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1297-301. PubMed ID: 11029334
[TBL] [Abstract][Full Text] [Related]
7. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
Lu S; Liu N; Dass SB; Reiss TF
J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
[TBL] [Abstract][Full Text] [Related]
8. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
Berkman N; Avital A; Bardach E; Springer C; Breuer R; Godfrey S
Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
[TBL] [Abstract][Full Text] [Related]
9. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial.
Price DB; Swern A; Tozzi CA; Philip G; Polos P
Allergy; 2006 Jun; 61(6):737-42. PubMed ID: 16677244
[TBL] [Abstract][Full Text] [Related]
10. Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study.
Profita M; Riccobono L; Bonanno A; Chanez P; Gagliardo R; Montalbano AM; Albano GD; Liotta G; Gjomarkaj M; La Grutta S
Int Arch Allergy Immunol; 2013; 161(1):53-64. PubMed ID: 23257680
[TBL] [Abstract][Full Text] [Related]
11. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
Rand C; Bilderback A; Schiller K; Edelman JM; Hustad CM; Zeiger RS;
J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
[TBL] [Abstract][Full Text] [Related]
12. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis.
Wilson AM; Orr LC; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Jan; 31(1):61-8. PubMed ID: 11167952
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
14. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study.
Rimmer J; Peake HL; Santos CM; Lean M; Bardin P; Robson R; Haumann B; Loehrer F; Handel ML
Clin Exp Allergy; 2007 Jan; 37(1):8-14. PubMed ID: 17210036
[TBL] [Abstract][Full Text] [Related]
15. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
16. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
[TBL] [Abstract][Full Text] [Related]
17. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
18. Nasal nitric oxide and nasal eosinophils decrease with levocetirizine in subjects with perennial allergic rhinitis.
Bautista AP; Eisenlohr CP; Lanz MJ
Am J Rhinol Allergy; 2011; 25(6):383-7. PubMed ID: 22185740
[TBL] [Abstract][Full Text] [Related]
19. [Effects of H1 blocker and inhaled corticosteroids on asthmatic patients with allergic rhinitis].
He WQ; Zheng JP; Ran PX; Liu HZ; Lin H; Cai DM; Xu JM; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):157-60. PubMed ID: 12816681
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]